Login / Signup

¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Rune SundsetHege Sagstuen HaugnesAlexander PerezOla EngelsenIda H H FosseideMiguel J CastillejoTrond Velde Bogsrud
Published in: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke (2024)
Treatment with [¹⁷⁷Lu]PSMA radioligand resulted in a temporary regression of the metastases.
Keyphrases
  • pet ct
  • pet imaging
  • squamous cell carcinoma
  • small cell lung cancer
  • computed tomography
  • replacement therapy